CPA
ITCI icon

Cowen Prime Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cowen Prime Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,150
Closed -$27K – 308
2015
Q1 		$27K Buy
+1,150
New +$25.8K 0.01% 210

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Advisors
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cowen Prime Advisors's ITCI Position: Q2 2015 in Review

Cowen Prime Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2015, closing a stake of 1,150 shares — an estimated $27K sold.

Cowen Prime Advisors first reported a position in ITCI in Q1 2015 and held it in 1 quarter. The position peaked at $27K in Q1 2015. 91 funds tracked by Wall St. Rank hold ITCI as of Q2 2015.

  • Cowen Prime Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2015 after selling out during the quarter.
  • Cowen Prime Advisors sold 1,150 Intra-Cellular Therapies Inc. shares in Q2 2015, an estimated $27K.
  • Cowen Prime Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2015 and held it in 1 quarter.
  • Cowen Prime Advisors's Intra-Cellular Therapies Inc. position peaked at $27K in Q1 2015.
  • 91 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2015.

Based on Cowen Prime Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.